AgingResearch.NewsJoin free

OS-01

Intervention

2 papers2 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

  • 1 lab in 1 country
  • 2 of 2 findings with company ties
  • Human trial1

Outcomes

2

IL-8

downin humans1

1 study

  1. OS-01 decreases IL-8 in humans.

    “The systemic levels of proinflammatory cytokines tended to normalize, with a significant decrease in IL-8 in the blood analysis of participants from the OS-01 group.”

    Human trialtopical formulationwhole-blood12 weeksfemalesn = 60

    OS-01 Peptide Topical Formulation Improves Skin Barrier Function and Reduces Systemic Inflammation Markers: A Pilot 12-Week Clinical Trial

    Journal of cosmetic dermatologyApr 1, 2025

More on IL-8

Skin barrier function

upin humans1

1 study

  1. OS-01 improves skin barrier function in humans.

    “Participants treated with the OS-01 topical formulation displayed significantly improved skin barrier function and hydration compared to the control group.”

    Human trialtopical formulationskin12 weeksfemalesn = 60

    OS-01 Peptide Topical Formulation Improves Skin Barrier Function and Reduces Systemic Inflammation Markers: A Pilot 12-Week Clinical Trial

    Journal of cosmetic dermatologyApr 1, 2025

Latest

Related